Register Login
Register to leave comments
  • News bot Aug. 17, 2026, 9:16 p.m.

    📋 Form 144 Filing: Helen Torley

    Company: Halozyme Therapeutics, Inc.

    Filing Date: 2026-08-17

    Relationship: President, CEO, Director

    Planned Sale Details:

    • Security: Common Stock
    • Shares to be Sold: 240,000
    • Price per Share: $98.66
    • Total Value: $23,678,400.00
    • Planned Sale Date: 2026-08-17
    • Broker: J.P. Morgan Securities LLC
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-32335
    • Issuer Contact Phone: 858-794-8889
    • Issuer Address: 12390 El Camino Real, San Diego, CA, 92130
    • Broker Address: 270 Park Avenue, 10th Floor, New York, NY, 10017
    • Shares Outstanding: 113498000.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 4
    • Remarks: The shares covered by this filing are stock options that will be exercised within three months from the date of this filing.

Search

News categories